HT
CARM

HAP Trading’s Carisma Therapeutics CARM Stock Holding History

HAP Trading’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,995
Closed -$5K – 1239
2022
Q4 		$5K Sell
10,995
-45
-0.4% -$473 ﹤0.01% 1229
2022
Q3 		$11K Buy
11,040
+100
+0.9% +$1.36K ﹤0.01% 1298
2022
Q2 		$54K Buy
10,940
+790
+8% +$9.04K ﹤0.01% 1034
2022
Q1 		$20K Buy
10,150
+6,315
+165% +$88.2K ﹤0.01% 1561
2021
Q4 		$9K Buy
3,835
+1,550
+68% +$31.2K ﹤0.01% 2079
2021
Q3 		$2K Buy
2,285
+915
+67% +$43.9K ﹤0.01% 2297
2021
Q2 		$35K Buy
1,370
+50
+4% +$3.19K ﹤0.01% 1605
2021
Q1 		$11K Buy
1,320
+535
+68% +$25.2K ﹤0.01% 1615
2020
Q4 		$4K Sell
785
-1,095
-58% -$27.8K ﹤0.01% 2046
2020
Q3 		$18K Buy
+1,880
New +$37.6K ﹤0.01% 1186
2018
Q3 		– Sell
-9,405
Closed -$18K – 1007
2018
Q2 		$18K Buy
+9,405
New +$414K ﹤0.01% 810

Other funds holding CARM

TOTUOP
Trustees of The University of Pennsylvania Philaldelphia, Pennsylvania $297M AUM
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DCM
Deuterium Capital Management Clearwater, Florida $86M AUM 87.31% 1-Year Est. Return
WIM
Wittenberg Investment Management Carlisle, Massachusetts $269M AUM 28.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HAP Trading's CARM Position: Q3 2021 in Review

HAP Trading sold out of Carisma Therapeutics (CARM) in Q3 2021, closing a stake of 4,550 shares — an estimated $218K sold.

HAP Trading first reported a position in CARM in Q1 2021 and held it in 2 quarters. The position peaked at $420K in Q2 2021. 103 funds tracked by Wall St. Rank hold CARM as of Q3 2021.

  • HAP Trading reported no remaining Carisma Therapeutics position as of Q3 2021 after selling out during the quarter.
  • HAP Trading sold 4,550 Carisma Therapeutics shares in Q3 2021, an estimated $218K.
  • HAP Trading first reported a position in Carisma Therapeutics in Q1 2021 and held it in 2 quarters.
  • HAP Trading's Carisma Therapeutics position peaked at $420K in Q2 2021.
  • 103 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q3 2021.

Based on HAP Trading's 13F filing for Q3 2021, filed 10 Nov 2021.